April 22, 2015
ReShape dual-balloon system
Stories this photo appears in:
San Clemente-based ReShape Lifesciences Inc. (Nasdaq: RSLS) raised nearly $1.5 million from several institutional investors for the purchase of 374,572 shares of its common stock at $3.92 per share, according to filings with the Securities and Exchange Commission.
San Clemente-based ReShape Medical Inc. said the Food and Drug Administration approved its ReShape Integrated Dual Balloon device for non-surgical weight loss.
San Clemente-based medical device maker ReShape Medical Inc. has received a $12 million loan from a pair of financiers.